Four years ago, my colleague and management team member here at BBK Worldwide, Rob Laurens, wrote the blog post, “How a Poster Enrolled my Clinical Trial.” I re-read it recently and thought it would be fun to look back on this article to see how our ideas about patient engagement and enrollment may have changed over the last few years thanks to technology and the rise of mHealth.
At last, patient centricity is much more than an industry buzzword. We’re seeing real efforts to put patients at the center of clinical research, and it’s beginning to impact all areas across the clinical research continuum.
With more than half of 2015 behind us it is clear that this is the year of wearables. When Fitbit, Inc. hit Wall Street in June it was the third largest U.S. IPO of the year according to Dealogic. While this fitness-tracking wearable developer is now valued at around $4.1 billion and poised for growth, what does this say about the future of wearables in the healthcare market? What does the long-term viability look like for this market?
According to TheDataLab, the use of mobile apps in clinical trials has shown to increase patient adherence and completion rates from just over 50% to over 80%. This and other figures are pointing to a shift in how data-driven mobile app development is drastically transforming how diseases are being treated – both inside and outside of the clinical trial setting. Why is data-driven methodology in mobile app development transforming healthcare and disease management?
The 51st Annual DIA Meeting kicked off yesterday in Washington, DC. So far it has been a whirlwind of presenting, networking and having fun at our booth (#2026 come see us)! DIA is the perfect time to announce the latest in company news, and we have no shortage of announcements to share this year.
In earlier posts we have explored how mHealth can increase both patient engagement and site engagement. Today’s blog comes from Jason Rightmyer, Director of Research Informatics with the Institute of Aging Research (a Harvard Medical School Affiliate) who explores how mobile health technology is attributing to physician engagement. Thanks for contributing!
During our recent webinar, “mHealth + Patient Engagement: A New Connected Health Model”, our panelists, Dan Bender (Empatica), Larry Suarez (Oracle) and Jaime Cohen (BBK Worldwide) received many thought-provoking questions throughout the hour. While we were able to answer a few on the spot, there were many that we didn’t have time to address. Below, Jaime takes a turn answering your burning questions.
BBK Worldwide is once again looking forward to attending Drug Information Association 2015 (DIA), which this year will take place from June 15 - 18 at the Walter E. Washington Convention Center in DC. We always love attending this annual event – the industry’s largest, which attracts more than 7,000 attendees each year. DIA provides a global, unbiased platform to raise the level of discussion to facilitate innovation that will change the future of healthcare.
Just about everyone carries a mobile device these days. Whether you’re in line for your morning coffee or on the treadmill at the gym, most people have their phones close at hand. So how can we utilize today’s connected mHealth model to better tap into clinical trial patients through means they are already using, such as their phones?
Devices like mobile phones and smartwatches are giving patients a new platform to contribute powerful, real-time data to medical researchers, but how do we make sure their contributions are truly heard and used to impact clinical research? Lily Cappelletti, Director of Research Engagement with The Michael J. Fox Foundation for Parkinson’s Research (MJFF), is today’s blog contributor. Read on to learn more about how her organization is utilizing mHealth to empower patients to make a difference through their own data and feedback.